Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0000899243-20-030415

Chief Operating Officer acquired 3,746 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pedersen Anders Chief Operating Officer 2020-11-02 Conversion +3,746 3,746 D
Derivatives
Pedersen Anders Chief Operating Officer 2020-06-24 Grant or award · Stock Option (right to buy) +142,983 142,983 D
Pedersen Anders Chief Operating Officer 2020-10-07 Grant or award · Stock Option (right to buy) +77,991 77,991 D
Pedersen Anders Chief Operating Officer 2020-11-02 Conversion · Series C-1 Preferred Stock −1,441 0 D
Loading xslF345X03/doc4.xml…